Please login to the form below

KOLs

This page shows the latest KOLs news and features for those working in and with pharma, biotech and healthcare.

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance. GlaxoSmithKline is to reverse its ban on paying healthcare professionals and key opinion leaders (KOLs), admitting that the policy has hit awareness of its ... GSK says it will now return to

Latest news

Taming the Monster

physicians and KOLs.
Signal strength

Certainly, as companies seek to build reputation and trust amongst KOLs, medical affairs teams will be central to demonstrating the transparency, scientific rigour and medical accountability that should underpin every communication
Harnessing the unrivalled power of key opinion leaders

Indeed, many pharma companies have been shown to wait until phase III has started before approaching KOLs. ... For example, some KOLs may be experts in clinical trial design while others might excel in public speaking.
Back to the future

For example, market access and KOL management are secondary to channel management and branding.
Connected Healthcare

Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

More from news
Approximately 2 fully matching, plus 105 partially matching documents found.

Latest Intelligence

Nudge-nudge, think-think

It’s a classic ‘nudge’. The principle is at the root of KOL work – but it applies equally to patients.
Developing advocacy in the pharmaceutical industry

Programme types are multiple and varied, and if you have a KOL or group of KOLs in mind, it is important to match your programme with their strengths and career status. ... But if you or your company is new to a therapy area, you may wish to use KOL
Understanding HCPs to build a meaningful brand

Conversely, your existing Key Opinion Leaders (KOLs) are already trusted among their peers but might appreciate help from their peers in developing their online networks. ... Consider empowering your existing KOLs to engage online. 3. Listen and learn.
Accelerating diagnosis in rare disease

Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for
A marathon and a sprint

At Lucid, we did it with oncology KOLs at a European congress. ... Although the congress had over 1, 000 delegates, the experience we created targeted only the top 15 KOLs in the therapy area.

More from intelligence
Approximately 7 fully matching, plus 31 partially matching documents found.

Latest from PMHub

PRMA Consulting Ltd

Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy.
How can pharma engage with key stakeholders on NHS service transformation?

Industry should also refine its proposition for transformation leads, medicines management staff and other key opinion leaders (KOLs), who may have different drivers and priorities. .
Developing advocacy in the pharmaceutical industry.

Programme types are multiple and varied, and if you have a KOL or group of KOLs in mind, it is important to match your programme with their strengths and career status. ... But if you or your company is new to a therapy area, you may wish to use KOL
Attigo (part of the Mednet Group)

Connecting you to your customer through:. KOL development. Advisory boards, steering groups, speaker training.
Introducing eConnext™: The Next Generation of Online Conference Engagement

Their eConnext solutions are ideal for KOL content sharing, speaker training and certification, continuing medical education, internal training, and for patient-HCP engagement.